Diagnostics

Advances in Alzheimer’s disease biomarkers & therapies

Greatest needs in dementia research: early diagnosis

Optimizing image segmentation tools for use in a clinical setting

Differences between Alzheimer’s disease biomarkers: p-Tau181, p-Tau231 & p-Tau217

The use of Alzheimer’s disease plasma biomarkers in the clinic: further research needed

Challenges in the clinical implementation of Alzheimer’s disease biomarkers

The MIRIADE training program: development of dementia biomarkers

Upcoming plasma biomarkers for Alzheimer’s disease: Aβ, p-tau and GFAP

The accuracy of plasma biomarkers for Alzheimer’s disease outside of a controlled setting

Revising the amyloid hypothesis in Alzheimer’s disease: the probabilistic model

Deep-learning tool can screen electronic health records to identify undiagnosed cognitive impairment

The PET-MR harmonization clinical study: PET-MR vs. PET-CT in dementia research

Plasma NfL as a biomarker for frontotemporal dementia

Alzheimer’s Research UK future research strategy

Diagnostic tools for neurodegenerative disease

Assessing psychosis in Alzheimer’s disease